Disrupted in schizophrenia 1 (DISC1) has been associated with risk of schizophrenia, schizoaffective disorder, bipolar disorder, major depression, autism and Asperger syndrome, but apart from in the original translocation family, true causal variants have yet to be confirmed. Here we report a harmonized association study for DISC1 in European cohorts of schizophrenia and bipolar disorder. We identify regions of significant association, demonstrate allele frequency heterogeneity and provide preliminary evidence for modifying interplay between variants. Whereas no associations survived permutation analysis in the combined data set, significant corrected associations were observed for bipolar disorder at rs1538979 in the Finnish cohorts (uncorrected P = 0.00020; corrected P = 0.016; odds ratio = 2.73 ± 95% confidence interval (CI) 1. 42-5.27) and at rs821577 in the London cohort (uncorrected P = 0.00070; corrected P = 0.040; odds ratio = 1.64±95% CI 1.23-2.19). The rs821577 single nucleotide polymorphism (SNP) showed evidence for increased risk within the combined European cohorts (odds ratio = 1.27 ± 95% CI 1.07-1.51), even though significant corrected association was not detected (uncorrected P = 0.0058; corrected P = 0.28). After conditioning the European data set on the two risk alleles, reanalysis revealed a third significant SNP association (uncorrected P = 0.00050; corrected P = 0.025). This SNP showed evidence for interplay, either increasing or decreasing risk, dependent upon the presence or absence of rs1538979 or rs821577. These findings provide further support for the role of DISC1 in psychiatric illness and demonstrate the presence of locus heterogeneity, with the effect that clinically relevant genetic variants may go undetected by standard analysis of combined cohorts.
Introduction
Schizophrenia and bipolar disorder are severely debilitating mental illnesses that jointly affect about 2% of the population.
1,2 Both conditions are highly heritable, with concordance rates of 50-80% in monozygotic twins and abundant evidence for familial clustering. 3, 4 Clinically diagnosed as separate disorders that generally cluster in different families, there is, however, growing evidence that the genetic risks for bipolar disorder and schizophrenia at least partially overlap. [5] [6] [7] [8] The case for disrupted in schizophrenia 1 (DISC1) as a risk factor in both schizophrenia and bipolar disorder derives from both genetic and biological evidence. DISC1 was originally identified at the breakpoint of a balanced t(1;11) translocation in a large Scottish pedigree multiply affected with psychiatric illness, including schizophrenia, bipolar disorder and recurrent major depression. 9, 10 DISC1 is expressed at half the normal levels in translocation cell lines, indicating that haploinsufficiency is the genetic model in this family. 11 Furthermore, the DISC1 protein acts as a scaffold for multiple protein interactions, including neurodevelopmental regulators (NDE1/NDEL1 and FEZ1 12 ) and neurosignalling regulators (PDE4B and PDE4D 11 ). Multiple association studies for psychiatric, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] cognitive, 15 ,27,28 memory 14, 29 and neuroimaging 14, 15, 22 phenotypes have now been reported for DISC1, but the overall picture is complicated, with allelic or haplotypic association reported over much of the DISC1 region ( Figure 1 ) with little evidence for convergence. 30 The principal problem for metaanalysis has been the low marker overlap between studies, as differing strategies have been adopted in single nucleotide polymorphism (SNP) selection and coverage. 30 To obtain a more harmonized view of the genetic evidence for DISC1 in schizophrenia and bipolar disorder, we undertook a large-scale association study combining four schizophrenia cohorts (total = 1275), three cohorts of bipolar disorder (total = 993) and population-matched control cohorts (total = 1263) from the European population.
Materials and methods

Cohorts
Each research centre (London, Edinburgh, Aberdeen and Finland) provided approximately 360 individual samples each for schizophrenia, bipolar disorder (predominantly type 1 but also type 2) and controls ( Table 1 ). All case diagnoses in all cohorts were made according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). 31 No bipolar disorder sample was available from the Aberdeen centre. Samples with a less than 90% genotyping success rate were removed from the analysis. The samples were derived from the study materials used previously in the independent Figure 1 Findings within the populations and cohorts and their relationship to the genomic map of disrupted in schizophrenia 1 (DISC1). Both images display the structure of the TSNAX and DISC1 genes (UCSC genome browser chromosome 1 bases 227961134 to 228493751; May 2004 build), the location of previous reports of association, the LD structure of the locus as the haplotype blocks that were analysed in this study along with the extended haplotypes and single nucleotide polymorphisms (SNPs). (a) Additionally shows the locations of the regions where significant associations were observed after correction for multiple testing (corrected Pp0.05, approximates to, uncorrected Pp0.0008). (b) Additionally shows the locations of the a priori observations separated by population and cohort. Light grey boxes represent P-values < 0.05 and > 0.01, dark grey boxes represent P-values < 0.01 and > 0.001, and black boxes represent P-values < 0.001.
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W Hennah et al research of these four groups. 13, 18, 26, [32] [33] [34] [35] [36] All samples were originally designed to test cases against controls, except for the Finnish sample. Affected individuals were selected from independent families within the Finnish family-based samples 13, 35 to ensure a true case-control design. In this sample, additional non-familial bipolar disorder cases were also used. 36 Controls for the Finnish cases were taken from the Finnish population-wide Health 2000 study (www.nationalbiobanks.fi).
SNP selection, genotyping and quality control
Using the HapMap CEU trio data, 37 SNPs with a minor allele frequency of X10% were selected from the genomic region 10 kb upstream of TSNAX to 10 kb downstream of DISC1 (Chr1:227961133-228493751; HapMap #20). A total of 866 SNPs were identified and uploaded into the HaploView program (version 4.0 beta 14). 38 Haplotype blocks were defined by solid spine of linkage disequilibrium (LD) (D 0 > 0.8). When examining haplotypes with a minor allele frequency of X1%, adjacent haplotype blocks for which Hedrick's multiallelic D 0 X0.9 39 were joined, SNPs were selected that tag haplotypes with a frequency of X5% (60 htSNPs). SNPs located between haplotype blocks were also genotyped (seven SNPs). Additional SNPs were selected for genotyping on the basis of the following criteria: non-synonymous SNPs of TSNAX and DISC1 (four SNPs); or contributing to interesting findings from previous publications but not within the HapMap selection criteria (four SNPs). All samples were genotyped at a single centre on the same Sequenom platform. 40 SNPs were later rejected from this selection if they had a genotyping success rate < 90% (six SNPs) or were monomorphic in these cohorts (two SNPs). The successfully genotyped SNPs showed no deviation from the expected Hardy-Weinberg equilibrium (P > 0.001) in the whole control data set. Haploview computes Hardy-Weinberg equilibrium with a w 2 goodness-of-fit test, using the default significance threshold of P = 0.001 as a cutoff, to balance the possibility of multiple testing artefacts against the occurrence of methodological problems or structural abnormalities. If an SNP was not in Hardy-Weinberg equilibrium (P < 0.001) or was below 90% success rate in an individual cohort, then it was to be removed from only that data set (two SNPs in the Aberdeen cohort: rs11122381 and rs1341553; and one SNP in the Finnish cohorts:
rs821633; all three due to genotype success rates < 90%). After applying these criteria, 67 of the originally selected 75 SNPs were of sufficient quality for analysis, spanning B530 kb and 20 haplotype blocks ( Figure 1 and Supplementary Table 1) . Association testing was performed using the 67 SNPs genotyped successfully, the 20 haplotype blocks tagged by a subset of these SNPs and extended haplotypes representative of haplotypic regions identified in previous reports ( Figure 1 ).
Association analysis and multiple test correction
The full set of association tests were performed by Haploview on multiple population and phenotype combinations. The populations tested included the European (London, Edinburgh, Aberdeen and Finland), British, (London, Edinburgh and Aberdeen) and Scottish (Edinburgh and Aberdeen) combinations of cohorts as well as the four cohorts separately. The phenotypes used in the analysis were (a) a combined schizophrenia, bipolar disorder type I and type II, (b) schizophrenia only, (c) combined bipolar disorder type I and type II and (d) bipolar disorder type I only. Owing to the previous reports of sex-limited effects 13, 16, 18 association tests were performed for combined male-and female-specific samples under each phenotype and population. A total of 84 models are possible under these combinations. However, as a bipolar disorder cohort was not available from Aberdeen, 18 models could not be performed, meaning a total of 66 models were tested. All tests were subjected to permutation analysis of single markers and haplotypes (100 000 permutations) to correct for multiple testing. Results were considered significant with a corrected P-value < 0.05 (equivalent to an uncorrected P-value < 0.0008). Haploview provides a framework for permuting association results, to obtain a measure of significance, corrected for multiple testing biases, while maintaining the pattern of linkage disequilibrium within the sample. However, permutation analysis only accounted for the multiple SNPs and haplotypes tested under a single model of cohort, phenotype and gender. No additional Allele frequency heterogeneity at the associating SNPs was formally tested using the w 2 goodnessof-fit test using the allele counts in the relevant populations.
Conditional association analysis
Previously, we reported conditioning of the Finnish schizophrenia families for the HEP3 risk haplotype, 41 resulting in the emergence of NDE1 (a DISC1 interactor 12 ) as a new genome-wide linkage finding. This was further supported by association analysis. 41 Adapting this conditioning approach to association analysis, the European study cohort was divided on the basis of the associating SNPs, with all SNPs and haplotypes retested for association. Data was split depending on the observed genotype at the associated SNP locus. For example, at rs1538979 the sample was split into two groups, those individuals carrying the T risk allele (TT and TC) and those not carrying the T risk allele (CC). The resulting groups were reanalysed for association, with respect to phenotype and gender. As previously described, 100 000 permutations were performed to correct for the multiple testing within each model, but no additional correction was implemented between the models. Odds ratios of the modulating effect of the three variants compared the number of individuals carrying the specified variants to the rest of the combined cohorts. This was carried out only in the British cohorts, as one of the SNPs of interest (rs821633) did not satisfy our genotyping success rate criteria in the Finnish cohorts, meaning that we were unable to discern the effect of the two variants in the presence or absence of this SNP.
Tests of a priori observations
Single nucleotide polymorphisms and haplotypes that either directly or indirectly targeted the areas of previous association (Figure 1b and Supplementary  Table 2 ) at this genomic locus were also studied without permutation correction owing to the a priori nature of these tests. Regions containing previously identified SNPs and haplotypes were aligned on the haplotype block structure in this study, and the aligned region analysed. Therefore, although we were not testing the exact variant previously noted, we monitored all haplotypes of X5% frequency in the locus specified. Previously noted haplotypes were not tested in this study if analysis of the LD pattern in the HapMap CEU Caucasian sample displayed multiallelic D 0 < 0.2 between haplotype blocks within these regions. These points of LD breakdown were also noted in our study sample (Figure 1) . Analyses of haplotypes traversing these regions are very likely to produce haplotypes of low frequency with an increased probability of errors from the expectation maximization (EM) algorithm affecting these frequencies. Results were considered significant with an uncorrected P-value < 0.05.
Results
Results of previous studies demonstrate that SNPs and haplotypes in multiple regions across TSNAX/ DISC1 associate with schizophrenia and/or bipolar disorder (Figure 1 ). In our harmonized approach to study multiple population cohorts, no SNP or haplotype association survived permutation correction (min uncorrected P = 0.0043; corrected P = 0.21) in the combined European cohorts. All uncorrected associations are listed in Supplementary Tables 3-4 . However, significant evidence for association was observed for rs1538979 in the Finnish bipolar disorder type I males (block 5 (B11.9 kb); uncorrected P = 0.00020; corrected P = 0.016; 14.0% cases, 4.6% controls; odds ratio = 2.73±95% CI 1.42-5.27; risk allele = T) and for rs821577 in the London bipolar disorder females (block 13 (B29.9 kb); uncorrected P = 0.00070; corrected P = 0.04; 46.7% cases, 34.8% controls; odds ratio = 1.64 ± 95% CI 1.23-2.19; risk allele = G). Odds ratios for the two significant SNPs for all phenotypes in all samples are displayed in Supplementary Table 5 . Further, the SNP rs821577 G risk allele showed evidence for increased risk within the combined cohorts to bipolar disorder (odds ratio = 1.28±95% CI 1.07-1.55) and bipolar disorder females (odds ratio = 1.44 ± 95% CI 1.12-1.85), even though significant corrected association was not detected (bipolar disorder uncorrected P = 0.012; corrected P = 0.47: bipolar disorder females uncorrected P = 0.0058; corrected P = 0.28). Although the rs1538979 SNP detected in the Finnish cohorts did not display significant odds ratios in the cohort combinations, it did in two additional individual cohorts, the T allele being a risk factor in the London sample with bipolar disorder females (odds ratio = 1.50 ± 95% CI 1.00-2.25; uncorrected P = 0.046, corrected P = 0.90) and a protective factor in the Aberdeen schizophrenia males (odds ratio = 0.55 ± 95% CI 0.36-0.83; uncorrected P = 0.0049, corrected P = 0.23) (Supplementary Table 5 ). We therefore performed heterogeneity analysis with these two associating SNPs, detecting a significant allele frequency difference between the Finnish and UK cohort controls for rs1538979 but not for rs821577 (Table 2) . To account for the effects of heterogeneity, conditional analysis of the European cohorts was performed by separating all individuals on inheritance or non-inheritance of a risk allele, to identify additional genetic factors within this region. This revealed an SNP, rs821633, that showed increased risk in combination with the risk T allele at rs1538979 in schizophrenia females (block 15 (B4.9 kb); uncorrected P = 0.00050; corrected P = 0.025; 44.8% cases, 27.0% controls; risk allele = C). This SNP also demonstrated uncorrected significance in the European cohorts for schizophrenia females before conditioning (uncorrected P = 0.021; corrected P = 0.66), although as this SNP did not meet our quality controls in the Finnish cohorts, this finding should be noted to be within the British cohorts. Association analysis conditional on rs821577 or rs821633 revealed no additional risk variants. The potential modular effects of the three variants identified here were studied through the measurement of the odds ratios of the markers independent or dependent on the genetic background at the other two loci in the British cohorts (Figure 2 ). This demonstrated that although rs821577 and rs821633 are risk factors independent of genetic background, rs1538979 is only a risk factor in the presence of rs821633. Additionally, rs821633 on its own is in fact a protective variant. It is only when rs821633 is present in combination with either or both of the other two variants that it becomes a risk factor in these British cohorts (Figure 2, Supplementary Figure 1 and Supplementary Table 6 ).
When studying our data with respect to the a priori observations, the genomic region covering 10 kb upstream of TSNAX to intron 8 of DISC1 displayed the most consistent replication of findings and contained two restricted regions that were identified in all cohorts tested (Figure 1b) : block 5, which indirectly Figure 2 Schematic to show the odds ratios and 95% confidence intervals for the three variants independent or dependent on the presence of other risk variants in the British cohorts, where the 95% confidence intervals both are either greater than or less than 1. Black squares represent schizophrenia, whereas black diamonds represent schizophrenia females. White squares represent bipolar disorder, with white diamonds representing bipolar disorder females. (Figure 1b) . Block 5 contains rs1538979 and further highlights this region as important to all cohorts. However, both block 5 and blocks 6-7 display their most significant associations to different phenotypic and gender models and with different haplotypes depending on the cohort studied. Of the SNPs that have been directly tested, rs6675281 (Leu607Phe) 16 is replicated only in the Edinburgh sample (bipolar disorder males, uncorrected P = 0.033), whereas rs1322784 16, 18, 24 is replicated in both the Finnish (schizophrenia females, uncorrected P = 0.049) and London (schizophrenia and bipolar disorder females combined, uncorrected P = 0.028) samples (Figure 1b) . The SNP most studied in the literature, 15, 22, 27, 28 rs821616 (Ser704Cys), did not display any significant association under any of the 66 models tested in this study.
Discussion
As in many previous studies of DISC1 in psychiatric illness, we have identified a number of loci that do not appear to be restricted to a certain clinical phenotype in their association. We have identified three regions represented by single SNPs, rs1538979 and rs821577 identified in individual cohorts and rs821633 identified after association analysis conditioned on the risk allele at rs1538979. SNP rs821577 displayed an increased odds ratio (odds ratio = 1.27±95% CI 1.07-1.51) in the combined European cohorts and did not display heterogeneity between the samples, suggesting that it may represent a common ancient variant. Similar to rs821577, rs821633 also displayed an increased odds ratio of schizophrenia in females (odds ratio = 1.50 ± 95% CI 1.15-1.95) for the combined European cohorts, suggesting that it too may play an important role across populations. By contrast, the T allele at rs1538979 displays alternate risk or protection depending on cohort and is heterogeneous over data sets; although located in an a priori replicated region (block 5), this region displays a lack of consistency between data sets as to which allele, phenotype and gender difference is associated, and its effect on risk. This suggests that although this genomic region, and the rs1538979 locus in particular, is still likely to play a role in psychiatric illness, there may be different causative variations depending on population, which may also be reliant on the presence or absence of additional modifying factors.
Although rs821577 and rs821633 were detected as risk factors for psychiatric illness independent of DISC1 genetic background in the European cohorts, with rs1538979 a risk factor in the Finnish cohorts. Each variant individually and in the absence of others is either neutral for risk or, in the case of rs821633, protective. It is the specific combination of DISC1 variants that results in elevated risk. This observed switching of effect between elevated and reduced risk may have a bearing on the evolutionary origins of these two disorders and go some way to explain why such devastating illnesses have such high and stable frequencies. Such a mechanism is consistent with the balancing selection hypothesis, which allows for variants to remain in the gene pool that are detrimental on certain genetic and/or environmental backgrounds but protective under others. 42 That DISC1 mediates risk of schizophrenia or bipolar disorder depending not just on the presence of one risk variant on the gene, but also on the presence or absence of other risk variants within the same gene, suggests that a new level of analysis is needed to take into account the stratification of genetic risk and the complexity of phenotypic association. Studies, such as this one, that increase the sample size in order to increase the power to detect association need to be aware that heterogeneity is also increased and may, at a superficial level of analysis, mask risk variants that are specific to certain subgroups or have a number of modifiers that affect the power to detect them in large samples. This may in part be due to computational limitations that result in the sole use of two-point analysis in initial phases. Therefore, the results from the large-scale genome wide associations for psychiatric illness, 43, 44 should be considered the end of the beginning, not the end in themselves, as further analysis of these very large data sets is likely to be productive. As it was only through methodical extension of standard association analysis that our hidden third variant (rs821633) and the presence of interplay were revealed. Observations of interplay are not novel and indeed should be expected in studies of complex genetics. 45 A recent example comes from a study of Alzheimer's disease, where variation in the cholesteryl ester transfer protein (CETP) gene was noted to increase risk only in the absence of the apolipoprotein E (APOE) risk variant. 46 Analysis of our data in the light of the prior observations demonstrates that the genomic region from 10 kb upstream of TSNAX to intron 8 of DISC1 is the most consistently replicated finding. It contains two restricted loci (block 5 and blocks 6-7) that demonstrated association within all cohorts. This region has already been highlighted by numerous studies, 13, 16, 18, 19, [24] [25] [26] a number of which also noted that this region displayed sex-dependent effects showing stronger association to affected males. 13, 18, 24, 26, 29 Such gender differences were again noted here throughout this genomic region, though not consistently with males in all cohorts. The phenotype and allele that produced the best P-value in this region also varied between the cohorts, again reflective of the previous findings that have highlighted this region with different disorders and variants.
Interestingly, despite direct testing and its numerous positive reports 15 15, 22 although these studies report association to opposing alleles. As has been suggested, these associations may reflect an LD effect rather than a direct functional consequence of the Ser or Cys variant per se.
15 Two SNPs did demonstrate direct replication in this study. SNP rs6675281, the nonsynonymous SNP causing the amino acid change Leu607Phe, was replicated in the Edinburgh sample with bipolar disorder males when it was originally observed to associate with schizoaffective disorder. 16 SNP rs1322784, identified as a risk factor in a Finnish sample for Asperger syndrome, 24 displays association with schizophrenia in the Finnish sample and combined schizophrenia and bipolar disorder in the London sample. In both samples, the association is predominantly with females. Additionally, this SNP has previously been noted to associate with bipolar disorder females (Region 3), 18 and with schizophrenia (Haplo block 2) 16 when studied alongside other SNPs in a haplotype. We have considered whether independent replication might be directly obtained by inspection of published and pending genome-wide association scans for schizophrenia and bipolar disorder. A comparison of the ability of these platforms to tag for our three associated SNPs (Supplementary Table 7 ) demonstrates that the Affymetrix platforms would not capture the required information content, whereas the Illumina platform may be adequate. Therefore, some platforms will be unable to confirm our findings through hypothesis-based tests, suggesting that direct testing of the three associated SNPs is preferable.
Genes of medical importance are generally larger and more complex in their regulation than the norm. 47 It is also recognized that genes such as DISC1, which act as 'hubs' with multiple connectivity, exert a greater portion of pathway control. 48, 49 Such modulatory targets are prime candidates for risk factors in complex genetic disorders, providing a potential complexity of phenotypic outcome through dosage, point mutation and epigenetic effects. The example presented here of multiple risk variants in DISC1 demonstrating interplay and switching of phenotypic effect may therefore be of general relevance. Our data provide further genetic support for a role of DISC1 in psychiatric illness, with the same variants on the same gene modulating risk to both bipolar disorder and schizophrenia, further substantiating the hypothesis that these two separate disorders have overlapping genetic risks. [5] [6] [7] [8] 
